SCHEMBL623082

SCHEMBL623082

CCOC(=O)C(OC1CCCC1)c1ccc(S(=O)(=O)C2CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCK P35557 18/20 0.46
LNPEP Q9UIQ6 1/20 0.40
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624347 0.99 GCK (0.46) GCKLNPEPLMNA
SCHEMBL184921 0.91 GCK (0.57) GCK
SCHEMBL184977 0.85 GCK (0.52) GCK
SCHEMBL624697 0.83 GCK (0.50) GCKLNPEP
SCHEMBL624577 0.82 GCK (0.49) GCKLNPEP
SCHEMBL623545 0.81 GCK (0.55) GCK
SCHEMBL185043 0.78 RAB9A (0.41) GCKLMNA
SCHEMBL624655 0.78 GCK (0.56) GCK
SCHEMBL4258573 0.78 GCK (0.48) GCK
SCHEMBL27103875 0.78 SLC6A2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed